These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 241617

  • 21. Metabolism of 14C-estazolam in dogs and humans.
    Machinist JM, Bopp BA, Anderson DJ, Granneman GR, Sonders RC, Tolman K, Buchi K, Rollins D.
    Xenobiotica; 1986 Jan; 16(1):11-20. PubMed ID: 2868576
    [Abstract] [Full Text] [Related]

  • 22. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
    Vickers S, Duncan CA, Slaughter DE, Arison BH, Greber T, Olah TV, Vyas KP.
    Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
    [Abstract] [Full Text] [Related]

  • 23. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH, Painter SK, Krieter PA, Colletti AE, Lyszack E, Rosegay A, Dean D, Luffer-Atlas D, Miller RR, Cioffe C, Chiu SH.
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [Abstract] [Full Text] [Related]

  • 24. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
    Huskey SE, Dean BJ, Doss GA, Wang Z, Hop CE, Anari R, Finke PE, Robichaud AJ, Zhang M, Wang B, Strauss JR, Cunningham PK, Feeney WP, Franklin RB, Baillie TA, Chiu SH.
    Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
    [Abstract] [Full Text] [Related]

  • 25. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S, Miura M, Toriumi C, Satoh Y, Ooie T.
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [Abstract] [Full Text] [Related]

  • 26. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C, Soliman V.
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [Abstract] [Full Text] [Related]

  • 27. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C, Kamel A, Gummerus J, Wilner K.
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [Abstract] [Full Text] [Related]

  • 28. Metabolism of amlodipine in the rat and the dog: a species difference.
    Beresford AP, Macrae PV, Stopher DA.
    Xenobiotica; 1988 Feb; 18(2):169-82. PubMed ID: 2967592
    [Abstract] [Full Text] [Related]

  • 29. Biotransformation of the novel inotropic agent toborinone (OPC-18790) in rats and dogs. Evidence for the formation of novel glutathione and two cysteine conjugates.
    Kitani M, Miyamoto G, Nagasawa M, Yamada T, Matsubara J, Uchida M, Odomi M.
    Drug Metab Dispos; 1997 Jun; 25(6):663-74. PubMed ID: 9193867
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Disposition of triprolidine in the male beagle dog.
    McNulty MJ, Deal DL, Page TL, Chandrasurin P, Findlay JW.
    Drug Metab Dispos; 1992 Jun; 20(6):928-35. PubMed ID: 1362948
    [Abstract] [Full Text] [Related]

  • 33. Species differences in the metabolism of suprofen in laboratory animals and man.
    Mori Y, Kuroda N, Sakai Y, Yokoya F, Toyoshi K, Baba S.
    Drug Metab Dispos; 1985 Jun; 13(2):239-45. PubMed ID: 2859175
    [Abstract] [Full Text] [Related]

  • 34. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C, Kamel A, Anderson W, Howard H.
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
    Denissen JF, Grabowski BA, Johnson MK, Buko AM, Kempf DJ, Thomas SB, Surber BW.
    Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
    [Abstract] [Full Text] [Related]

  • 37. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM, Bao J, Smith RL, McClure TD, Mayersohn M, Pillai U, Cunningham ML, Sipes IG.
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [Abstract] [Full Text] [Related]

  • 38. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C, Cui D.
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [Abstract] [Full Text] [Related]

  • 39. Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans.
    Carlin JR, Höglund P, Eriksson LO, Christofalo P, Gregoire SL, Taylor AM, Andersson KE.
    Drug Metab Dispos; 1992 Dec; 20(2):148-55. PubMed ID: 1352203
    [Abstract] [Full Text] [Related]

  • 40. Metabolic fate of premazepam, a new anti-anxiety drug, in the rat and the dog.
    Assandri A, Barone D, Ferrari P, Perazzi A, Ripamonti A, Tuan G, Zerilli LF.
    Drug Metab Dispos; 1984 Dec; 12(2):257-63. PubMed ID: 6144494
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.